CD14 and cancer: Metascape analysis (Zhou et al. 2019) revealed that several prominent pathways were enriched in CD14+ monocytes type I (based on upregulated genes; adjusted p value ≤ 0.05), including hemostasis, clotting cascade, platelet activation, cytokine signalling, and transcriptional dysregulation in cancer (Suppl.